Anatomical and Functional Consequences of Chronic Migraine
Posted on May 09 2025,
Anatomical and Functional Consequences of Chronic Migraine:
Introduction
For many people with migraine, their condition is episodic. Without seeing a neurologist or headache specialist and following an appropriate treatment plan, episodic migraine may progress to chronic migraine [1].
The transformation from episodic to chronic migraine occurs when headache is present on 15 or more days per month for more than 3 months, with migraine features on at least 8 days per month. This chronification occurs in approximately 2.5% of migraine patients annually, while reversion from chronic to episodic migraine happens much less frequently [2].
The goal is to prevent the disability associated with chronic migraine by preventing the transformation from episodic to chronic migraine. Moreover, inadequately treating migraine can result in neurological and possibly structural changes [3].
Why This Matters
Understanding the anatomical and functional consequences of chronic migraine is essential for developing effective prevention and treatment strategies. Recent advances in neuroimaging techniques have revealed complex patterns of brain alterations associated with migraine chronification [4].
Sensory Changes and Central Sensitization
Patients with chronic migraine experience several neurological changes compared to those with episodic migraine. For example, cutaneous allodynia occurs more frequently in people with chronic migraine versus episodic migraine [5].
Cutaneous Allodynia
Cutaneous allodynia refers to the experience of pain from non-painful stimuli that typically do not provoke pain. For example, people with cutaneous allodynia may perceive pain from something as benign as combing their hair. This finding suggests that people with chronic migraine are more susceptible to central sensitization in the nervous system, causing previously non-painful stimuli to trigger painful responses [6].
An increase in nausea is also more common in chronic migraine patients versus episodic migraine, further contributing to disability [7]. Photophobia and phonophobia have also been linked to the development of chronic migraine and are associated with trigeminal hypersensitivity [8].
Hypothalamic and Brain Network Changes
Studies show changes in the hypothalamus in chronic migraine patients compared to those with episodic migraine [9]. As migraine frequency increases (the defining criteria between episodic and chronic), some brain regions demonstrate heightened activation including areas involved in pain reception, sensory processing, and autonomic regulation while other regions important for executive function and emotion processing show decreased coordination between neural networks [10, 11].
Brain Volume Changes
Changes in brain volume occur as migraine attacks increase in frequency and the disease duration increases [12]:
There is also accumulation of iron in the periaqueductal gray matter, which can potentially serve as a biomarker for chronic migraine [13].
White Matter Lesions
White matter lesions may be visible on MRI in migraine patients. Studies have found that higher attack frequency and longer disease duration positively correlate with white matter lesions [14]. However, this is an increasingly controversial topic as of 2025 with some studies suggesting no relation.
Longitudinal Structural Brain Changes in Migraine
A 2025 study by Planchuelo-Gómez et al. has provided important insights into the long-term evolution of brain structure in migraine patients [31]. This longitudinal study, with follow-up periods between 3-7 years, examined structural changes in both gray matter (GM) and white matter (WM) across different migraine progression patterns.
Key Findings from Longitudinal Research
- Different clinical progression patterns are linked to distinct structural brain changes over time
- Patients with stable episodic migraine showed increased cortical thickness in temporal and parietal regions
- Patients with stable chronic migraine exhibited decreased cortical thickness in the posterior cingulate gyrus
- Remarkably, patients who improved from chronic to episodic migraine showed no significant GM changes
The research followed three groups of patients: those with stable episodic migraine (EM), those with stable chronic migraine (CM), and those who improved from CM to EM. Using advanced MRI techniques including diffusion tensor imaging and morphometry parameters, the team identified unique structural adaptation patterns associated with different clinical courses [31].
Longitudinal changes were particularly significant in the posterior cingulate gyrus, an area involved in pain processing and perception. Both stable EM and CM groups showed a decrease in cortical thickness in this region (annual relative changes of 0.34% and 0.51% respectively), while patients who improved from CM to EM showed no significant changes [31].
In white matter analysis, patients with stable EM showed increased fractional anisotropy in the cerebral peduncle, a region involved in motor control, sensory relay, and pain processing. These findings suggest that GM is more susceptible to disruption than WM, with the rates of change considerably lower in WM structures [31].
According to Planchuelo-Gómez et al., "The changes observed in regions associated with central pain processing differ from those in other areas related to the migraine experience that are not directly involved in pain processing. Maladaptive changes, which were particularly evident in individuals with 'stable' CM, contrast with adaptive changes seen in those with 'stable' EM." [31]
This longitudinal research provides compelling evidence that the brain adapts differently to stable and changing clinical conditions in migraine, with important implications for understanding disease progression and potentially informing treatment approaches.
Microstructural White Matter and Cortical Gray Matter Changes in Migraine (2025)
A groundbreaking 2025 study by Li et al. published in The Journal of Headache and Pain has revealed important insights into microstructural alterations in both white matter (WM) and cortical gray matter (GM) in migraine patients [32]. This study utilized advanced neuroimaging techniques including Diffusion Tensor Imaging (DTI) and Neurite Orientation Dispersion and Density Imaging (NODDI) to investigate microstructural changes at a level not previously possible.
Key Findings on Microstructural Changes
- Neurite loss detected in both white matter and cortical gray matter of migraineurs
- More severe axonal damage and demyelination in chronic migraine compared to episodic migraine
- Right-hemispheric predominance of neurite alterations in migraine patients
- Correlation between neurite damage and neurotransmitter systems
The research team studied 40 chronic migraine patients, 35 episodic migraine patients, and 45 healthy controls using these advanced neuroimaging techniques. Compared to healthy controls, migraine patients showed reduced neurite density in several white matter tracts, including the superior longitudinal fasciculus (SLF), inferior longitudinal fasciculus (ILF), inferior frontal-occipital fasciculus (IFOF), and uncinate fasciculus (UF) [32].
Chronic migraine patients exhibited more pronounced microstructural damage than those with episodic migraine, showing both reduced neurite density and increased radial diffusivity, suggesting significant axonal demyelination. Notably, these changes were predominantly in the right hemisphere, a finding that warrants further investigation [32].
In the cortical gray matter, migraineurs showed decreased neurites in the right insula and temporal pole cortex, areas involved in pain processing, multisensory integration, and emotional regulation. Patients with chronic migraine specifically demonstrated reduced neurites in the right middle temporal and fusiform cortex [32].
According to Li et al., "Our observed findings support the hypothesis of neuronal remodeling and neurotransmitter alterations in migraine and its subtypes. It provides preliminary evidence for the pathological mechanisms involving impaired brain microstructure and neurotransmitter imbalance following repeated nociception stimuli." [32]
Importantly, the study also investigated the relationship between microstructural changes and neurotransmitter systems, finding that neurite damage in cortical gray matter negatively correlated with several neurotransmitter distributions, including serotonin transporter (SERT), dopamine D2 receptors, dopamine transporter (DAT), and FDOPA. This suggests potential interactions between neurotransmitter imbalances and structural alterations in migraine pathophysiology [32].
Recent Advances in Migraine Neuroimaging
Key Neuroimaging Advances
- Increased connectivity in pain matrix in chronic migraine patients
- Functional imaging of prodrome phase providing novel insights
- Identification of potential biomarkers specific to migraine with aura
- Advanced 7 Tesla MRI revealing differences in medication overuse headache
Functional Connectivity Changes
Recent neuroimaging studies have provided deeper insights into the functional differences between chronic and episodic migraine. Research has identified increased connectivity in the pain matrix in chronic migraine patients during the interictal period, using advanced resting-state functional MRI techniques [15]. This suggests persistent alterations in pain processing networks even between attacks in chronic migraine patients. A 2024 study by Frimpong-Manson et al. further characterized these neural pathways, demonstrating how third-order neural projections from the thalamus can undergo aberrant stimulation leading to somatic symptoms of migraine [16].
Prodrome Phase Imaging
Advances in human migraine research, particularly the use of functional imaging techniques lacking radiation exposure, have created exciting opportunities to study the prodrome phase using repeated measures imaging designs. These studies have provided novel insights into attack initiation, migraine neurochemistry, and potential therapeutic targets [17]. Recent work by Karsan (2024) has demonstrated that the ability to scan patients repeatedly with non-invasive imaging modalities has allowed for reproducible imaging of the prodrome phase using nitroglycerin as a trigger [18].
Migraine with Aura Biomarkers
Recent fMRI studies have identified potential biomarkers specific to migraine with aura. A January 2025 study showed that the visual cortex in these patients exhibits distinctive activation patterns, reflecting underlying cortical dysfunction that persists beyond acute episodes, potentially due to chronic neuronal dysregulation or hyperexcitability [19]. This research provides further evidence for cortical spreading depression as a basic mechanism underlying migraine with aura.
Medication Overuse/Adaptation Headache Neuroimaging
A 2025 study by Sun et al. using 7 Tesla multimodal MRI found significant neuroimaging differences between chronic migraine patients with and without medication overuse headache [20]. This advanced imaging approach, combining structural, diffusion tensor, and functional imaging, has characterized distinct brain abnormalities in these patient groups and investigated the relationship between acute analgesic use frequency and these changes. The study demonstrated that medication overuse leads to specific neurobiological alterations that differ from those seen in chronic migraine alone.
Choroid Plexus Volume and Association with Migraine (2025)
What is the Choroid Plexus?
The choroid plexus is located inside the ventricular system of the brain. It forms the blood-cerebrospinal fluid barrier and plays vital roles in maintaining brain homeostasis, including cerebrospinal fluid production and clearance [21]. Recent research has identified the choroid plexus as an important neuroimmunological interface involved in various neurological conditions [22].
A 2025 study by Xiong et al. has identified the choroid plexus as a significant structure in migraine pathophysiology [23]. The research recruited 65 participants (18 with episodic migraine, 16 with chronic migraine, and 31 healthy controls) who underwent brain MRI examinations. The research team used FreeSurfer (Version 7.4.1) software to automatically segment and measure the choroid plexus volume.
Key Findings on Choroid Plexus Volume
- Differential changes in choroid plexus volume: Episodic migraine patients showed decreased choroid plexus to lateral ventricle (CP/LV) ratio, while chronic migraine patients exhibited increased CP/LV ratio compared to controls [23].
- Diagnostic potential: The right-side CP/LV ratio could differentiate episodic migraine from controls with area under the ROC curve (AUC) of 0.696 (95% CI: 0.550-0.818), sensitivity of 100%, and specificity of 46.8%. The diagnostic efficacy was even higher in distinguishing chronic migraine from episodic migraine with AUC of 0.715 (95% CI: 0.536-0.856) [23].
- Correlation with clinical features: Patients with migraine demonstrated increased anxiety, depression, heavier headache burden, and impaired cognitive abilities compared to controls [23].
- Dynamic alterations: The findings suggest dynamic changes in lateral ventricular choroid plexus volume during migraine pathogenesis, with the normalized CP/LV ratio associated with different migraine subtypes [24].
This research suggests that normalized CP/LV measurements could potentially serve as an imaging biomarker for migraine diagnosis and classification. The changes in choroid plexus volume may reflect underlying mechanisms of peripheral-central interaction in migraine, which has been hypothesized but lacked direct evidence until now [23].
Migraine Comorbidities
Besides neurological and anatomical changes, migraine also comes with comorbidities [25]. Increased central sensitization and activation of the trigeminovascular pathway due to migraine play roles in the pathogenesis of other pain syndromes as well.
Frequent migraine attacks result in ongoing inflammation and activation of certain nerve fibers in the trigeminal system. This leads to the release of more CGRP and other neuropeptides that promote inflammation and sensitization of trigeminal nerves [26]. This sensitization leads to changes in pain processing networks in the brain, which in turn leads to migraine chronification and other comorbidities.
Major Comorbidities with Chronic Migraine
- Anxiety and depression
- Sleep disorders
- Other chronic pain syndromes
- Cognitive dysfunction
- Vestibular symptoms
Conclusion
Understanding the anatomical and functional consequences of chronic migraine is essential for developing effective prevention and treatment strategies. Recent advances in neuroimaging techniques have revealed complex patterns of brain alterations associated with migraine chronification [27].
The identification of the choroid plexus as a structure involved in migraine pathophysiology opens new avenues for research and potential therapeutic targets [28]. The evidence of dynamic alterations in choroid plexus volume associated with different migraine subtypes may eventually lead to improved diagnostic criteria and personalized treatment approaches.
Longitudinal research by Planchuelo-Gómez et al. has shown that the brain adapts differently to stable versus changing clinical conditions, with patients improving from chronic to episodic migraine showing fewer structural brain changes than those with stable migraine conditions [31]. These findings suggest potential neuroplasticity mechanisms that could be therapeutic targets.
The 2025 microstructural analysis by Li et al. has added a critical new dimension to our understanding, revealing that neurite damage occurs in both white matter and cortical gray matter of migraine patients, with more pronounced damage in chronic migraine [32]. The correlation between these microstructural changes and neurotransmitter systems highlights the complex interplay between structural and neurochemical factors in migraine pathophysiology, offering potential new targets for treatment approaches.
Emerging therapeutic research targeting various pathways, including CGRP, PACAP, and other potential molecular targets, shows promise for migraine prevention and treatment [29]. According to a 2024 publication in The Lancet Neurology, early intervention with targeted therapies may lead to better outcomes for patients [30].
It is crucial to stop the progression from episodic to chronic migraine, as this transformation is associated with significant disability, neuroanatomical changes, and functional alterations. Effective management requires evidence-based approaches rather than unproven "hacks" and misinformation.
Summary Table
This table summarizes the key findings from current research on how chronic migraine affects brain structure and function, recent neuroimaging advances, and associated comorbidities.
Category | Key Findings |
---|---|
Definition & Chronification |
Chronic migraine defined as:
|
Sensory Changes |
|
Brain Volume Changes |
As migraine frequency and disease duration increase:
|
Neural Network Changes |
|
Longitudinal Structural Changes |
2025 study by Planchuelo-Gómez et al. found:
Suggests the brain adapts differently to stable versus changing clinical conditions |
Microstructural Changes (2025) |
2025 study by Li et al. found:
|
Choroid Plexus Findings (2025) |
Differential changes in choroid plexus volume:
|
Common Comorbidities |
Frequent migraine leads to ongoing inflammation and trigeminovascular activation:
|
References
- Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005;45(Suppl 1):S3-S13.
- Manack A, Buse DC, Serrano D, et al. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 2011;76(8):711-718.
- Dodick DW. Migraine. Lancet. 2018;391(10127):1315-1330.
- Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987-1993.
- Louter MA, Bosker JE, van Oosterhout WP, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain. 2013;136(Pt 11):3489-3496.
- Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47(5):614-624.
- Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27(5):394-402.
- Noseda R, Copenhagen D, Burstein R. Current understanding of photophobia, visual networks and headaches. Cephalalgia. 2019;39(13):1623-1634.
- Schulte LH, Allers A, May A. Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI. Neurology. 2017;88(21):2011-2016.
- Schwedt TJ, Chiang CC, Chong CD, et al. Functional MRI of migraine. Lancet Neurol. 2015;14(1):81-91.
- Mainero C, Boshyan J, Hadjikhani N. Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine. Ann Neurol. 2011;70(5):838-845.
- Kim JH, Suh SI, Seol HY, et al. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia. 2008;28(6):598-604.
- Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41(7):629-637.
- Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291(4):427-434.
- Sun Y, Ma L, Wang S, et al. Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study. J Headache Pain. 2019;20:100.
- Frimpong-Manson K, Ortiz YT, McMahon LR, Wilkerson JL. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. Front Mol Neurosci. 2024;17:1355281.
- Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol. 2018;14(12):699-710.
- Karsan N. Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review. J Headache Pain. 2024;25:10.
- Neurology International. fMRI Insights into Visual Cortex Dysfunction as a Biomarker for Migraine with Aura. Neurol Int. 2025;17(2):15.
- Sun Y, Ma L, Wang S, et al. Neuroimaging differences between chronic migraine with and without medication overuse headache: a 7 Tesla multimodal MRI study. J Headache Pain. 2025;26:54.
- Lun MP, Monuki ES, Lehtinen MK. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci. 2015;16(8):445-457.
- Diez-Cirarda M, Yus-Fuertes M, Delgado-Alonso C, et al. Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes. Mol Psychiatry. 2025. doi:10.1038/s41380-024-02886-x.
- Xiong J, Liu M, Li X, Chen Z. Choroid plexus volume and association with migraine Pathophysiology. Eur J Radiol. 2025;112:112135.
- Liu H, Liu H, Li H, et al. A volumetric study of the choroid plexus in neuropsychiatric systemic lupus erythematosus. Sci Rep. 2025;15:3663.
- Ashina S, Serrano D, Lipton RB, et al. Depression and risk of transformation of episodic to chronic migraine. J Headache Pain. 2012;13(8):615-624.
- Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338-350.
- Schulte LH, May A. Of generators, networks and migraine attacks. Curr Opin Neurol. 2017;30(3):241-245.
- Kolahi S, Zarei D, Issaiy M, et al. Choroid plexus volume changes in multiple sclerosis: insights from a systematic review and meta-analysis of magnetic resonance imaging studies. Neuroradiology. 2024;66:1869-1886.
- The Lancet Neurology. Potential treatment targets for migraine: emerging options and future prospects. Lancet Neurol. 2024. doi:10.1016/S1474-4422(24)00003-6.
- The Lancet Neurology. Headache research in 2024: new data on migraine prevention. Lancet Neurol. 2024. doi:10.1016/S1474-4422(24)00485-X.
- Planchuelo-Gómez Á, Martín-Martín C, Guerrero ÁL, García-Azorín D, de Luis-García R, Aja-Fernández S. Long-term evolution of white and gray matter structural properties in migraine. Headache. 2025;00:1-15. doi:10.1111/head.14949
- Li Z, Mei Y, Wang L, Fan T, Peng C, Zhang K, Wu S, Chen T, Zhang Z, Sui B, Wang Y, Yu X. White matter and cortical gray matter microstructural alterations in migraine: a NODDI and DTI analysis. J Headache Pain. 2025;26:115. doi:10.1186/s10194-025-02059-3
Mon, May 19, 25
Migraine and Headaches During Pregnancy & Postpartum
Comprehensive guidance on managing migraine and headaches during pregnancy and postpartum. Learn about effective treatments, safety considerations, and when to seek medical help. Discover evidence-based strategies for relief, including medication...
Read MoreMon, May 19, 25
Pharmaceutical Options for Migraine Prevention
A comprehensive guide to medication classes, efficacy, dosing, and considerations for personalized preventive treatment
Read MoreThu, May 15, 25
Modifiable Risk Factors for Migraine: What You Can Change
Table of modifiable migraine risk factors based on recent research
Read More